Evidence map›Paper›PMID 38868438›Full record

ReviewiMeta2023

Research advances in probiotic fermentation of Chinese herbal medicines.

Xiaoling Zhang, Qin Miao, Chengxue Pan, Jia Yin, Leli Wang, Lingbo Qu, Yulong Yin, Yongjun Wei

Abstract readReview
In one paragraph

Review in iMeta, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 52 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
52citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

52 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Effects ofAnimals : an open access journal from MDPI · 2026
    Article
  4. Article
  5. Article
  6. Article
  7. FermentedFoods (Basel, Switzerland) · 2026
    Article
  8. Article
  9. Bidirectional Fermentation ofFoods (Basel, Switzerland) · 2026
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Review
  20. Anti-GPV activity ofFrontiers in microbiology · 2026
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Xiaoling ZhangSchool of Pharmaceutical Sciences, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education Zhengzhou University Zhengzhou China.
Qin MiaoSchool of Pharmaceutical Sciences, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education Zhengzhou University Zhengzhou China.
Chengxue PanSchool of Pharmaceutical Sciences, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education Zhengzhou University Zhengzhou China.
Jia YinHunan Provincial Key Laboratory of Animal Intestinal Function and Regulation, College of Life Science Hunan Normal University Changsha China.
Leli WangHunan Provincial Key Laboratory of Animal Intestinal Function and Regulation, College of Life Science Hunan Normal University Changsha China.ORCID 0000-0002-1590-338X
Lingbo QuLaboratory of Synthetic Biology, Food Laboratory of Zhongyuan Zhengzhou University Zhengzhou China.
Yulong YinInstitute of Subtropical Agriculture Chinese Academy of Sciences Changsha China.
Yongjun WeiSchool of Pharmaceutical Sciences, Key Laboratory of Advanced Drug Preparation Technologies, Ministry of Education Zhengzhou University Zhengzhou China.ORCID https://orcid.org/0000-0002-1554-1999

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Chinese herbal medicines (CHM) have been used to cure diseases for thousands of years. However, the bioactive ingredients of CHM are complex, and some CHM natural products cannot be directly absorbed by humans and animals. Moreover, the contents of most bioactive ingredients in CHM are low, and some natural products are toxic to humans and animals. Fermentation of CHM could enhance CHM bioactivities and decrease the potential toxicities. The compositions and functions of the microorganisms play essential roles in CHM fermentation, which can affect the fermentation metabolites and pharmaceutical activities of the final fermentation products. During CHM fermentation, probiotics not only increase the contents of bioactive natural products, but also are beneficial for the host gut microbiota and immune system. This review summarizes the advantages of fermentation of CHM using probiotics, fermentation techniques, probiotic strains, and future development for CHM fermentation. Cutting-edge microbiome and synthetic biology tools would harness microbial cell factories to produce large amounts of bioactive natural products derived from CHM with low-cost, which would help speed up modern CHM biomanufacturing.

Indexed as

Chinese herbal medicinefermentationmicrobiomeprobioticssynthetic biology

Identifiers

PMID38868438
PMCPMC10989925

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.